期刊文献+

羟氯喹与环磷酰胺治疗狼疮性肾炎伴周围血管炎的临床分析 被引量:7

Analysis Clinical of Hydroxychloroquine and Cyclophosphamide in Treatment of Lupus Nephritis With Peripheral Vasculitis
在线阅读 下载PDF
导出
摘要 目的分析羟氯喹与环磷酰胺治疗狼疮性肾炎伴周围血管炎疗效。方法选取60例患者分为A、B组,每组各30例,分别以羟氯喹与环磷酰胺、环磷酰胺治疗。结果 A组治疗后症状、各实验指标优于B组,P<0.05,差异具有统计学意义,无严重不良反应。结论羟氯喹与环磷酰胺治疗狼疮性肾炎伴周围血管炎疗效显著。 Objective Analyze the effect on hydroxychloroquine and cyclophosphamide in treatment of lupus nephritis with peripheral vasculitis. Methods Selected 60 cases were divided into group A and group B, each group of 30 cases, respectively with hydroxychloroquine, and cyclophosphamide cyclophosphamide treatment. Results After treatment the A group symptoms were superior than the group B, P〈0.05, had difference statistically signiifcance, no serious adverse reaction. Conclusion Hydroxychloroquine and cyclophosphamide in treatment of lupus nephritis with peripheral vasculitis effect.
作者 于晶 张林
出处 《中国继续医学教育》 2015年第16期145-146,共2页 China Continuing Medical Education
关键词 羟氯喹 环磷酰胺 狼疮性肾炎 周围血管炎 Hydroxychloroquine, Cyclophosphamide, Lupus nephritis, Peripheral vasculitis
  • 相关文献

参考文献3

二级参考文献17

  • 1许晓燕,桑晓红.狼疮性肾炎的诊治分析[J].中国全科医学,2009,12(7):611-614. 被引量:12
  • 2程虹,谌贻璞.急进性肾小球肾炎的治疗进展[J].新医学,2005,36(7):385-385. 被引量:4
  • 3Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients [J]. Medicine (Baltimore) ,2006,85(2) :95-104.
  • 4Kasitanon N, Fine DM, Haas M, et al. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis [ J ]. Lupus ,2006,15(6 ) :366-370.
  • 5Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus [ J]. Medicine(Baltimore) ,2006,85 ( 3 ) : 147-156.
  • 6Bertsias G, loannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus crythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics [ J ]. Ann Rheum Dis ,2008,67 (2) : 195-205.
  • 7蒋明;DAVID YU;林孝义.风湿病学,2004.
  • 8Cortes-Hemandez J;Ordi-Ros J;Labrador M.Predictors of poor renal outcome in patients with lupus nephritis treated with combined pulses of cyclophosphamide and methylpredrisolone,2003(04).
  • 9韩伟.系统性红斑狼疮的健康教育[J].中国医药导报,2008,5(3):149-150. 被引量:5
  • 10李玲,周雪玲,段春梅.系统性红斑狼疮的护理[J].中国医药导报,2009,6(3):101-102. 被引量:8

共引文献15

同被引文献61

  • 1翁燕蓉,彭才智,曾铁云,杭春风.甲基泼尼松龙和环磷酰胺联合冲击治疗狼疮肾炎的护理干预[J].湖北医药学院学报,2012,31(1):76-78. 被引量:10
  • 2李大军,李云霞,车航.来氟米特联合吗替麦考酚酯治疗狼疮性肾炎的疗效观察[J].中华临床医师杂志(电子版),2014,01(05):853-857.
  • 3Xu S, Liu Z, Chen H, et al. Diffuse segmental and pure diffuse global proliferative glomerulonephritis:different patterns of class IV lupusn nephritis[J]. Clin Nephrol,2014,81 (6) :411-418.
  • 4Appel G B, Contreras G, Dooley M A, et al. Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis [J]. J Am Soc Nephrol,2009,20(5) :1103-1112.
  • 5Tarzi R M, Cook H T, Pusey C D. Crescentic glomerulonephritis : new aspects of pathogenesis[ J]. Semin Nephro1,2011,31 (4) :361-368.
  • 6Mak A, Cheak A A, Tan J Y, et al. Mycophenolate mofetil is as effica- cious as, but safer than, cyclophosphamide in the treatment of prolif- erative lupus nephritis : a meta - analysis and meta - regression [ J ]. Rheumatology(Oxford) ,2009,48 (8) :944-952.
  • 7Chen S,Tang Z,Zhang Y, et al. Significance of histological crescent formation in patients with diffuse proliferative lupus nephritis [ J ]. Am J Nephrol,2013,38(6) :445-452.
  • 8Oudah N, A1 Duhailib Z, Alsaad K, et al. Glomerulonephritis with crescents among adult saudi patients outcome and its predictors [ J ]. Cline Exp Med ,2012,12 ( 2 ) : 121-125.
  • 9胡伟新.吗替麦考酚酯治疗狼疮性肾炎及血管炎展望[J].肾脏病与透析肾移植杂志,2012,7(3):264.
  • 10李元宁.90例羟氯喹治疗狼疮性肾炎伴周围血管炎的安全性观察[J].医药前沿,2014,04(34):190-191.

引证文献7

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部